Fundraising FoxHealthtech Startups
18,778 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
Revitope Oncology is a biotechnology company developing precision cancer immunotherapies using its TwoGATE T cell engager platform, which uses paired tumor-targeted bispecific antibodies that become active only on cancer cells co-expressing two antigens to limit toxicity to healthy tissue. Its pipeline focuses on solid tumor indications, developed in-house and through partnerships with companies such as Genmab and Junshi Biosciences.
0 investors
0 investors
RevMedx develops hemorrhage-control medical devices, including the XSTAT expanding-sponge injector for junctional bleeding, ratcheting TX tourniquets, and compression wraps. Its products serve licensed medical professionals, first responders, and military users such as US Special Operations Forces.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Rezilir Health is a precision medicine clinic offering brain health, longevity, and complex chronic condition care, including therapies such as hyperbaric oxygen, IV infusions, ketamine, neurofeedback, and genetic testing. It serves patients with neurodegenerative disease, autoimmune disorders, dementia, and environmental illnesses from its Hollywood, Florida location.
0 investors
0 investors
Rheos Medical develops Clarity-IA, an anesthesia delivery system that converts existing hospital ventilators into the equivalent of a dedicated anesthesia machine for administering inhaled anesthetics and sedation during mechanical ventilation. The device is intended for use by trained healthcare professionals treating patients weighing 80-330 lbs.
0 investors
RheoTek Medical develops injection technology for aesthetic and medical applications including facial and hair aesthetics, medical dermatology, and skin cancer. Its platform, currently under clinical evaluation, aims to deliver precise injections targeting specific tissue layers (epidermis, dermis, fat, or muscle) with better dispersion and reduced pain.
0 investors
RheumaGen is a private biotechnology company developing one-time cell and gene therapies that edit the human leukocyte antigen (HLA) to treat autoimmune diseases at their source. It works with the University of Colorado Anschutz Medical Campus and its ClinImmune laboratory to advance clinical programs.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors